fashion -WSS

fashion

author：comprehensive 2025-09-30 17:59:36 - browse：3678

One Medical and Amazon Care apps displayed on a phone. -- health tech coverage from STAT. — Adobe

The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven. Out of their ashes, a new health strategy has emerged at the tech goliath. And while its leaders insist that Amazon has no grand plan for health care, a flurry of moves in the last year offer a glimpse into its ambitions at a time when they seem more cohesive than ever.

“We have learned a lot in the years that we’ve been dabbling in health care,” said Sunita Mishra, chief medical officer for Amazon Health Services. “And it’s now made us more confident that we’re on the right track.”

STAT spoke to four of Amazon’s chief medical officers about the company’s recent plays and how they fit into the company’s health care goals. Last November, it launched Amazon Clinic, a marketplace for virtual-only appointments for straightforward medical needs like pink eye, UTIs, and birth control. Two months later, its Amazon Pharmacy business launched RxPass, a $5 generic medication discount program, setting it up as a Walmart rival. And in February, it closed the acquisition of hybrid primary care company One Medical in a deal valued at $3.9 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Trump’s hydroxychloroquine hype: a risk to my treatment and to him

hotspot

WSS

Questions and answers about ramping up H5N1 bird flu vaccine

Security flaws in third

Addressing health care workers' trauma can help fight burnout

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

For longer

'Screen and refer' systems are hurting patients

hotspot

fashion

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

As a primary care physician, here's how I hope to partner with AI

At least 13 dead in Texas as scorching temps continue

Crowdfunding for unproven stem cell procedures spreads misinformation

Medicare details structure of new drug price negotiation program

Investigation reveals sickle cell patients pressured into sterilizations

BioMarin wins approval for gene therapy to treat hemophilia A

Undocumented workers face uncertainty as immigration law takes effect in Florida

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

entertainment

H5N1 virus can be tracked in retail milk, scientists say

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Prescription digital therapeutics are key to pharma’s future

knowledge

hotspot

focus

focus